A 30-Month Evaluation of the Effects on the Cost and Utilization of Proton Pump Inhibitors From Adding Omeprazole OTC to Drug Benefit Coverage in a State Employee Health Plan

Journal of Managed Care Pharmacy
doi 10.18553/jmcp.2006.12.1.25
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Academy of Managed Care Pharmacy

Related search

The Role of Proton Pump Inhibitors in Renal Disease - The Risk of Using OTC Drugs

Farmacja Polska
2019English

Overprescribing Proton Pump Inhibitors & a Glimpse on Its Side Effects

Advanced Research in Gastroenterology & Hepatology
2017English

Antiplatelet Drug Interactions With Proton Pump Inhibitors

Expert Opinion on Drug Metabolism and Toxicology
MedicineToxicologyPharmacology
2013English

Pleotropic Effects of Proton Pump Inhibitors Guest Editor: Yuji Naito Endoscopic Submucosal Dissection in the Era of Proton Pump Inhibitors

Journal of Clinical Biochemistry and Nutrition
MedicineNutritionClinical BiochemistryDietetics
2009English

Cost Variation Analysis of Proton Pump Inhibitors Available in Indian Market

International Journal of Basic & Clinical Pharmacology
2018English

The Effects of a 30-Month Dietary Intervention on Bone Mineral Density: The Postmenopausal Health Study

British Journal of Nutrition
MedicineNutritionDietetics
2010English

Characteristics of Proton Pump Inhibitors Utilization in Postacute Phase of Ischemic Heart Disease

Cardiologia Croatica
Cardiovascular MedicineCardiology
2014English

The Proton Pump Inhibitor Omeprazole Does Not Promote Clostridioides Difficile Colonization in a Murine Model

mSphere
MicrobiologyMolecular Biology
2019English

A Relationship Between Proton Pump Inhibitors and Hypomagnesemia?

Mayo Clinic Proceedings
Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy